er Data from 809 patients receiving Nespo in European clinical studies were analysed to assess the dose ng required to maintain haemoglobin; no difference was observed between the average weekly dose administered via the intravenous or subcutaneous routes of injection. lo
Δεδομένα από 809 ασθενείς που έλαβαν Nespo σε Ευρωπαϊκές κλινικές μελέτες αναλύθηκαν για την υτ